Table 1 Cohort demographics.

From: Residual serum fibrinogen as a universal biomarker for all serotypes of Myasthenia gravis

Myasthenia gravis

n = 31

 Average age (years)

59.0 ± 23.9(range 19–93)

 Gender (M/F, %)

51.6% / 48.4%

 Average on-set age

54.7(range 15–86)

 Early/Late on-set (%)

35.5%/64.5%

 Disease severity (MGFA)

 Class I

25.8%

  Class II

32.3%

  Class III

41.9%

Control

n = 30

 Average age (years)

48.2 ± 17.1(range 21–86)

 Gender (M/F, %)

40/60

Rheumatoid arthritis

n = 18

 Average age (years)

65.1 ± 11.7(range 36–81)

 Gender (M/F, %)

33.3/66.7

  1. Demographic information and clinical profiles of the three groups of individuals from which sera were collected for fibrinogen protein analysis. As per the Myasthenia Gravis Foundation of America (MGFA) classification, Class I represents purely ocular from of MG, Class II represents mild generalized MG and Class III describes moderately severe generalized MG.
Back to article page